Lewis Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Lewis Asset Management's LLY Position: Q3 2026 in Review
Lewis Asset Management increased its Eli Lilly (LLY) stake by 2% in Q3 2026, buying an estimated $63.7K and bringing the position to 2,724 shares worth $3.15M. The position accounts for 1.07% of the portfolio, ranked #20.
Lewis Asset Management first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $3.2M in Q2 2026. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Lewis Asset Management held 2,724 shares of Eli Lilly worth $3.15M as of Q3 2026.
- Lewis Asset Management bought 54 Eli Lilly shares in Q3 2026, an estimated $63.7K.
- Eli Lilly made up 1.07% of Lewis Asset Management's portfolio in Q3 2026, its #20 holding.
- Lewis Asset Management first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
- Lewis Asset Management's Eli Lilly position peaked at $3.2M in Q2 2026.
- 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Lewis Asset Management's 13F filing for Q3 2026, filed 14 Oct 2026.